Deep Genomics vs Sarepta
Deep Genomics vs Sarepta, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Deep Genomics is on 61/100 and Sarepta on 21/100.
Where each one leads
Deep Genomics
- our overall score: 61/100 against 21/100
Sarepta
- domain rating: 68/100 against 54/100
- headcount: 1,162 against 110
- LinkedIn following: 138,724 against 30,891
At a glance
| Measure | Deep Genomics | Sarepta |
|---|---|---|
| What it is | AI-powered biotechnology company developing RNA therapeutics for genetic diseases. | Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases. |
| Category | Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2015 | Not published |
| Headquarters | Toronto, Canada | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Deep Genomics | Sarepta |
|---|---|---|
| Employees | 110 | 1,162 |
| Headcount growthLast 12 months | +19.3% | Not published |
| Open roles | Not published | 19 |
| Total funding | $241M | Not published |
| Latest round | Series C | Not published |
| LinkedIn followers | 30,891 | 138,724 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Deep Genomics | Sarepta |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 21/100 |
| Traction | 60/100 | 20/100 |
| Team | 60/100 | Not published |
| Search visibility | 33/100 | 25/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 68/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Deep Genomics | Sarepta |
|---|---|---|
| Hosting | Self Managed | AWS |
| CDN | Not detected | Cloudflare |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4, Segment | Not detected |
What users say
| Measure | Deep Genomics | Sarepta |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“Sarepta Therapeutics is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. $SRP”r/
Deep Genomics vs Sarepta: common questions
Which is better, Deep Genomics or Sarepta?
On our 0-100 score Deep Genomics rates higher (61/100 against 21/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Deep Genomics and Sarepta compare on the numbers?
Deep Genomics leads on our overall score (61/100 against 21/100). Sarepta leads on domain rating (68/100 against 54/100), headcount (1,162 against 110), LinkedIn following (138,724 against 30,891).
What do real users say about Deep Genomics and Sarepta?
Sarepta: 1 positive and 0 negative mentions across 1 Reddit threads we track.
Read the full Deep Genomics review and pricing or the Sarepta review and pricing. You can also browse other Deep Genomics alternatives we track.